QuantX Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 30

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $85M

  • Investors
  • 6

QuantX General Information

Description

Developer of computational drug discovery technology designed for oral small-molecule therapeutics for immunology and inflammation. The company leverages advanced computation and modeling to accelerate the discovery of superior oral small-molecule medicines against validated immunology and inflammation targets, enabling biopharma partners and patients to benefit from faster, more efficient development of next-generation therapies.

Contact Information

Website
quantxbio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 103 Carnegie Center
  • Suite 309
  • Princeton, NJ 08540
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • 103 Carnegie Center
  • Suite 309
  • Princeton, NJ 08540
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

QuantX Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series B) 22-Dec-2025 $85M Completed Pre-Clinical Trials
1. Early Stage VC Completed Pre-Clinical Trials
To view QuantX’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

QuantX Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

QuantX Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Creacion Ventures Venture Capital Minority
Hongshan Technology VC-Backed Company Minority
LAV (Lilly Asia Fund) Corporate Venture Capital Minority
OrbiMed Growth/Expansion Minority
Sanofi Ventures Corporate Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

Ready to get started?

Request a free trial

QuantX FAQs

  • When was QuantX founded?

    QuantX was founded in 2022.

  • Where is QuantX headquartered?

    QuantX is headquartered in Princeton, NJ.

  • What is the size of QuantX?

    QuantX has 30 total employees.

  • What industry is QuantX in?

    QuantX’s primary industry is Drug Discovery.

  • Is QuantX a private or public company?

    QuantX is a Private company.

  • What is QuantX’s current revenue?

    The current revenue for QuantX is .

  • How much funding has QuantX raised over time?

    QuantX has raised $130M.

  • Who are QuantX’s investors?

    Creacion Ventures, Hongshan Technology, LAV (Lilly Asia Fund), OrbiMed, and Sanofi Ventures are 5 of 6 investors who have invested in QuantX.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process